Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-02-05 00:00:00 ET · period of report 2024-02-01 · accession 0001968202-24-000048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-05 | 2024-02-01 | REGN | RYAN ARTHUR F | Dir | S - Sale | $954.22 | -100 | 18.5K | -0.5% | -$95.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | S | D | 6 | $941.91 | 18,475 | D | — | — | (F2) Represents volume-weighted average price of sales of 6 shares of Company stock on February 1, 2024 at prices ranging from $941.83 to $941.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 2 | Common | Common Stock | 2024-02-01 | S | D | 5 | $942.50 | 18,470 | D | — | — | (F3) Represents volume-weighted average price of sales of 5 shares of Company stock on February 1, 2024 at prices ranging from $942.03 to $942.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 3 | Common | Common Stock | 2024-02-01 | S | D | 1 | $939.53 | 18,481 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-01 | S | D | 4 | $963.73 | 18,382 | D | — | — | (F19) Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2024 at prices ranging from $963.54 to $963.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 5 | Common | Common Stock | 2024-02-01 | S | D | 4 | $961.37 | 18,392 | D | — | — | (F17) Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2024 at prices ranging from $961.00 to $961.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 6 | Common | Common Stock | 2024-02-01 | S | D | 6 | $962.49 | 18,386 | D | — | — | (F18) Represents volume-weighted average price of sales of 6 shares of Company stock on February 1, 2024 at prices ranging from $962.20 to $962.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 7 | Common | Common Stock | 2024-02-01 | S | D | 10 | $960.52 | 18,396 | D | — | — | (F16) Represents volume-weighted average price of sales of 10 shares of Company stock on February 1, 2024 at prices ranging from $960.18 to $960.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 8 | Common | Common Stock | 2024-02-01 | S | D | 8 | $959.68 | 18,406 | D | — | — | (F15) Represents volume-weighted average price of sales of 8 shares of Company stock on February 1, 2024 at prices ranging from $959.14 to $959.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 9 | Common | Common Stock | 2024-02-01 | S | D | 5 | $958.65 | 18,414 | D | — | — | (F14) Represents volume-weighted average price of sales of 5 shares of Company stock on February 1, 2024 at prices ranging from $958.48 to $958.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 10 | Common | Common Stock | 2024-02-01 | S | D | 3 | $957.75 | 18,419 | D | — | — | (F13) Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2024 at prices ranging from $957.32 to $957.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 11 | Common | Common Stock | 2024-02-01 | S | D | 7 | $956.21 | 18,422 | D | — | — | (F12) Represents volume-weighted average price of sales of 7 shares of Company stock on February 1, 2024 at prices ranging from $956.00 to $956.41. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 12 | Common | Common Stock | 2024-02-01 | S | D | 10 | $955.35 | 18,429 | D | — | — | (F11) Represents volume-weighted average price of sales of 10 shares of Company stock on February 1, 2024 at prices ranging from $955.11 to $955.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 13 | Common | Common Stock | 2024-02-01 | S | D | 5 | $954.52 | 18,439 | D | — | — | (F10) Represents volume-weighted average price of sales of 5 shares of Company stock on February 1, 2024 at prices ranging from $954.15 to $954.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 14 | Common | Common Stock | 2024-02-01 | S | D | 3 | $953.18 | 18,444 | D | — | — | (F9) Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2024 at prices ranging from $953.12 to $953.26. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 15 | Common | Common Stock | 2024-02-01 | S | D | 3 | $951.40 | 18,447 | D | — | — | (F8) Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2024 at prices ranging from $951.10 to $951.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 16 | Common | Common Stock | 2024-02-01 | S | D | 2 | $950.01 | 18,450 | D | — | — | (F7) Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2024 at prices ranging from $950.00 to $950.02. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 17 | Common | Common Stock | 2024-02-01 | S | D | 10 | $949.48 | 18,452 | D | — | — | (F6) Represents volume-weighted average price of sales of 10 shares of Company stock on February 1, 2024 at prices ranging from $949.13 to $949.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 18 | Common | Common Stock | 2024-02-01 | S | D | 1 | $948.77 | 18,462 | D | — | — | |
| 19 | Common | Common Stock | 2024-02-01 | S | D | 3 | $947.37 | 18,463 | D | — | — | (F5) Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2024 at prices ranging from $947.16 to $947.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |
| 20 | Common | Common Stock | 2024-02-01 | S | D | 1 | $944.66 | 18,466 | D | — | — | |
| 21 | Common | Common Stock | 2024-02-01 | S | D | 3 | $943.54 | 18,467 | D | — | — | (F4) Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2024 at prices ranging from $943.49 to $943.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price. |